Last reviewed · How we verify
1 month of PDE5i treatment — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
1 month of PDE5i treatment (1 month of PDE5i treatment) — Centre Hospitalier Universitaire de Nīmes.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| 1 month of PDE5i treatment TARGET | 1 month of PDE5i treatment | Centre Hospitalier Universitaire de Nīmes | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- 1 month of PDE5i treatment CI watch — RSS
- 1 month of PDE5i treatment CI watch — Atom
- 1 month of PDE5i treatment CI watch — JSON
- 1 month of PDE5i treatment alone — RSS
Cite this brief
Drug Landscape (2026). 1 month of PDE5i treatment — Competitive Intelligence Brief. https://druglandscape.com/ci/1-month-of-pde5i-treatment. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab